Doc's note: World War II brought a new boom to industry, but not everyone was happy about the new technological advancements.

Today, Marc Chaikin, founder of our corporate affiliate Chaikin Analytics, explains how these changes created an "automation hysteria" and how we're seeing it play out again today...

They thought Henry Ford II wanted to eliminate them... but he really gave them new life.

After World War II, a period of prosperity and rapid industrialization began in the U.S.

Factories that previously churned out bombers and tanks to support the war efforts were reborn. They started producing everything from refrigerators to TVs to new cars.

But folks didn't embrace all the changes of the postwar boom...

Workers at Ford Motor's (F) factory in Detroit went on a 25-day strike in 1949. The strike paralyzed the assembly line. And it eventually involved more than 100,000 workers.

The striking workers left hundreds of half-finished Tudor sedans sitting on the factory floor.

Specifically, they hated Ford Motor President and CEO Henry Ford II's plan to "automate" production. He wanted to add a modern stamping plant, two engine plants, and a foundry.

In other words, Ford wanted to use machines to make things more efficient.

Understandably, the idea of machines replacing human auto workers at the factory led to an "automation hysteria." Practically everyone in the plant thought they would lose their jobs.

In reality... the opposite happened.

Automation Is Here to Stay

The automation machines made cars faster than Ford's army of human workers. They could stamp, cut, weld, and spray paint faster – all without posing a risk to human health.

But the machines at the factory still needed human operators...

Someone had to move the cars from machine to machine throughout the assembly process. And the machines couldn't tell on their own if they needed to speed up or slow down.

The machines also couldn't tell if a bolt was out of place, a fender seemed out of shape, or if the paint was off. So when it came to ensuring quality, human workers were still essential.

After Ford introduced automation machinery, the company's annual production more than tripled from 1948 to 1957. And at the same time, its workforce grew 46%.

In other words, Ford's automation efforts didn't eliminate the army of human workers. The surge in productivity instead meant that the carmaker could scale its output many times higher.

Ford wasn't alone, either. The "golden age" of the U.S. car industry is well known today...

Every major carmaker pushed to automate its assembly lines around the same time. And annual U.S. car production boomed from 3.5 million in 1947 to 6.1 million in 1957.

That was only the start of U.S. carmakers shifting to more automation, of course.

The industry features roughly a third of all the country's industrial robots. An average carmaker operates hundreds of robots dedicated to simple tasks like machining and welding.

And these days, robots can do a lot more than just put cars together. Heck, these robots have eliminated the human element from many mundane and repetitive tasks in the manufacturing process.

Put simply, we've come a long way from the early days of automation – when workers feared for their jobs. Yet today, those early arguments are more familiar than ever...

We've all been hearing plenty of apocalyptic predictions about artificial intelligence ("AI").

It's all part of a new age of automation hysteria.

Of course, I don't have a crystal ball. So I can't say exactly what tomorrow will bring.

But I do know one thing for sure...

The AI narrative is still shaping the markets. As always, here at Chaikin Analytics, we'll be using the Power Gauge to find the best ways to capitalize... and navigate the market as it evolves.

Good investing,

Marc Chaikin

Editor's note: Marc's Power Gauge system flashed bullish on at least eight of the top 10 stocks every year from 2016 through 2024. Today, the Power Gauge is warning of a "January Trigger." Last week, Marc released his brand-new "Top 10 Stocks" list for 2026... along with a battle plan for the year ahead. Click here for all the details (and two free stock recommendations).

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top